Literature DB >> 19724232

Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography.

Thomas C Kwee1, Henriette M E Quarles van Ufford, Frederik J Beek, Taro Takahara, Cuno S Uiterwaal, Marc B Bierings, Inge Ludwig, Rob Fijnheer, Rutger A J Nievelstein.   

Abstract

PURPOSE: To assess the value of whole-body magnetic resonance imaging (MRI), including diffusion-weighted imaging (DWI), for the initial staging of malignant lymphoma, compared with computed tomography (CT).
MATERIALS AND METHODS: Thirty-one consecutive patients with newly diagnosed malignant lymphoma prospectively underwent whole-body MRI (T1-weighted and short inversion time inversion recovery [n = 31], and DWI [n = 28]) and CT. Ann Arbor stages were assigned by 1 radiologist according to whole-body MRI findings, and by another radiologist according to CT findings. Differences in staging between whole-body MRI (without and with DWI) and CT were resolved using other (imaging) studies (including 18F-fluoro-2-deoxyglucose positron emission tomography and bone marrow biopsy) and follow-up studies as reference standard.
RESULTS: Staging results of whole-body MRI without DWI were equal to those of CT in 74% (23/31), higher in 26% (8/31), and lower in 0% (0/31) of patients, with correct/incorrect/unresolved overstaging relative to CT in 3, 2, and 2 patients, respectively, and incorrect staging of both modalities in 1 patient. Staging results of whole-body MRI with DWI were equal to those of CT in 75% (21/28), higher in 25% (7/28), and lower in 0% (0/28) of patients, with correct/incorrect overstaging relative to CT in 6 and 1 patient(s), respectively.
CONCLUSION: Our results suggest that initial staging of malignant lymphoma using whole-body MRI (without DWI and with DWI) equals staging using CT in the majority of patients, whereas whole-body MRI never understaged relative to CT. Furthermore, whole-body MRI mostly correctly overstaged relative to CT, with a possible advantage of using DWI.

Entities:  

Mesh:

Year:  2009        PMID: 19724232     DOI: 10.1097/RLI.0b013e3181afbb36

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  26 in total

1.  Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group.

Authors:  Stephan D Voss; Lu Chen; Louis S Constine; Allen Chauvenet; Thomas J Fitzgerald; Sue C Kaste; Thomas Slovis; Cindy L Schwartz
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

2.  Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma.

Authors:  Chieh Lin; Alain Luciani; Emmanuel Itti; Taoufik El-Gnaoui; Alexandre Vignaud; Pauline Beaussart; Shih-jui Lin; Karim Belhadj; Pierre Brugières; Eva Evangelista; Corinne Haioun; Michel Meignan; Alain Rahmouni
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

3.  Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?

Authors:  Christopher Klenk; Rakhee Gawande; Vy Thao Tran; Jennifer Trinh Leung; Kevin Chi; Daniel Owen; Sandra Luna-Fineman; Kathleen M Sakamoto; Alex McMillan; Andy Quon; Heike E Daldrup-Link
Journal:  J Nucl Med       Date:  2015-10-15       Impact factor: 10.057

4.  Quantitative breast MRI: 2D histogram analysis of diffusion tensor parameters in normal tissue.

Authors:  Julia Wiederer; Shila Pazahr; Cornelia Leo; Daniel Nanz; Andreas Boss
Journal:  MAGMA       Date:  2013-09-03       Impact factor: 2.310

Review 5.  Clinical pediatric positron emission tomography/magnetic resonance program: a guide to successful implementation.

Authors:  Sandra Saade-Lemus; Elad Nevo; Iman Soliman; Hansel J Otero; Ralph W Magee; Elizabeth T Drum; Lisa J States
Journal:  Pediatr Radiol       Date:  2020-02-19

6.  Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.

Authors:  Annalisa Balbo-Mussetto; Chiara Saviolo; Alberto Fornari; Daniela Gottardi; Massimo Petracchini; Annalisa Macera; Chiara Valentina Lario; Teresa Gallo; Corrado Tarella; Stefano Cirillo
Journal:  Radiol Med       Date:  2017-04-18       Impact factor: 3.469

7.  Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents?

Authors:  Rodrigo Regacini; Andrea Puchnick; Flavio Augusto Vercillo Luisi; Henrique Manoel Lederman
Journal:  Pediatr Radiol       Date:  2018-01-23

Review 8.  Whole-body diffusion-weighted imaging for staging malignant lymphoma in children.

Authors:  Thomas C Kwee; Taro Takahara; Malou A Vermoolen; Marc B Bierings; Willem P Mali; Rutger A J Nievelstein
Journal:  Pediatr Radiol       Date:  2010-07-30

9.  Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors.

Authors:  Maximilien Minon; Clothilde Soriano; David Morland; Thomas Walter; Côme Lepage; Antoine Tabarin; Mathilde Deblock; Pascal Rousset; Coralie Barbe; Christine Hoeffel; Guillaume Cadiot
Journal:  Endocrine       Date:  2019-09-28       Impact factor: 3.633

10.  Dynamic contrast-enhanced MRI improves accuracy for detecting focal splenic involvement in children and adolescents with Hodgkin disease.

Authors:  Shonit Punwani; King Kenneth Cheung; Nicholas Skipper; Nichola Bell; Alan Bainbridge; Stuart A Taylor; Ashley M Groves; Sharon F Hain; Simona Ben-Haim; Ananth Shankar; Stephen Daw; Steve Halligan; Paul D Humphries
Journal:  Pediatr Radiol       Date:  2013-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.